Goff DC - Search Results

1

Risperidone-associated hyperprolactinemia.

Kearns AE, Goff DC, Hayden DL, Daniels GH. Kearns AE, et al. Among authors: goff dc. Endocr Pract. 2000 Nov-Dec;6(6):425-9. doi: 10.4158/EP.6.6.425. Endocr Pract. 2000. PMID: 11155212

2

Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.

Henderson DC, Goff DC. Henderson DC, et al. Among authors: goff dc. J Clin Psychiatry. 1996 Sep;57(9):395-7. J Clin Psychiatry. 1996. PMID: 9746446 Clinical Trial.

3

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.

Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT. Goff DC, et al. Arch Gen Psychiatry. 1999 Jan;56(1):21-7. doi: 10.1001/archpsyc.56.1.21. Arch Gen Psychiatry. 1999. PMID: 9892252 Clinical Trial.

4

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.

Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, Goff DC. Henderson DC, et al. Among authors: goff dc. Am J Psychiatry. 2000 Jun;157(6):975-81. doi: 10.1176/appi.ajp.157.6.975. Am J Psychiatry. 2000. PMID: 10831479 Clinical Trial.

5

Effect of risperidone dose on serum prolactin level.

Daniels GH, Hayden DL, Goff DC, Kearns AE. Daniels GH, et al. Among authors: goff dc. Endocr Pract. 2001 May-Jun;7(3):224. doi: 10.4158/EP.7.3.224. Endocr Pract. 2001. PMID: 11421571 No abstract available.

6

Risperidone added to clozapine: impact on serum prolactin levels.

Henderson DC, Goff DC, Connolly CE, Borba CP, Hayden D. Henderson DC, et al. Among authors: goff dc. J Clin Psychiatry. 2001 Aug;62(8):605-8. doi: 10.4088/jcp.v62n0805. J Clin Psychiatry. 2001. PMID: 11561931

7

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.

Evins AE, Amico E, Posever TA, Toker R, Goff DC. Evins AE, et al. Among authors: goff dc. Schizophr Res. 2002 Jul 1;56(1-2):19-23. doi: 10.1016/s0920-9964(01)00220-1. Schizophr Res. 2002. PMID: 12084415 Clinical Trial.

8

Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations.

Freudenreich O, Goff DC. Freudenreich O, et al. Among authors: goff dc. Acta Psychiatr Scand. 2002 Nov;106(5):323-30. doi: 10.1034/j.1600-0447.2002.01331.x. Acta Psychiatr Scand. 2002. PMID: 12366465 Review.

9

Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents.

Naidoo U, Goff DC, Klibanski A. Naidoo U, et al. Among authors: goff dc. Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:97-108. doi: 10.1016/s0306-4530(02)00129-4. Psychoneuroendocrinology. 2003. PMID: 12650684 Review.

10

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Freudenreich O, et al. Among authors: goff dc. J Clin Psychiatry. 2004 Oct;65(10):1372-6. doi: 10.4088/jcp.v65n1012. J Clin Psychiatry. 2004. PMID: 15491241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

584 results

Search Page

Filters